This is a $207,498.00 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the National Institutes of Health (NIH), to Rigaku Americas Holding, Inc. (Rigaku Americas), a foreign-owned for-profit company. The contract is for a service agreement for various X-ray analysis instruments, including the MicroMax-007 HF, Eiger 4M X-ray detector, BioSAXS, and associated Automatic Sample Changer. The contract has a base year from May 1, 2019, to April 30, 2020, with two option years through March 31, 2022. The original procurement was conducted under simplified acquisition procedures without full and open competition. Rigaku Americas is the prime contractor and has previously worked with other prime contractors on federal contracts and grants related to advanced X-ray instrumentation and analysis.